Wai Yuen Tong Medicine Holdings Limited (HKG:0897)

HKG:0897 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	133.28	132.32	154.97	525.87	510.15
Short-Term Investments	0.2	0.46	8.13	0.81	19.84
Trading Asset Securities	10.01	9.93	28.75	41.76	99.76
Cash & Short-Term Investments	143.49	142.7	191.85	568.44	629.74
Cash Growth	0.56%	-25.62%	-66.25%	-9.73%	-3.70%
Accounts Receivable	55.31	67.35	81.36	68.03	63.35
Other Receivables	28.79	29.02	35.57	93.98	69.52
Receivables	164.1	196.37	216.92	195.32	176.14
Inventory	226.54	238.1	308.1	1,637	1,869
Prepaid Expenses	59.74	39.74	36.3	138.56	31.61
Restricted Cash	-	-	-	12.17	7.31
Other Current Assets	4.79	4.12	77.06	151.28	174.93
Total Current Assets	598.67	621.02	830.23	2,702	2,889
Property, Plant & Equipment	694.69	768.45	817.46	4,061	4,519
Long-Term Investments	6.73	6.68	29.42	197.39	151.07
Long-Term Deferred Tax Assets	21.05	21.05	17.69	11.63	0.05
Other Long-Term Assets	10.42	23.06	20.32	24.38	25.65
Total Assets	1,627	1,735	2,095	7,014	7,598

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	21.28	18.27	30.91	79.49	86.36
Short-Term Debt	279.29	187.35	184.75	608.69	570.26
Current Portion of Long-Term Debt	-	-	-	5.7	70
Current Portion of Leases	41.7	52.38	48.27	52.16	50.88
Current Income Taxes Payable	3.94	4.86	4.51	95.85	142.34
Current Unearned Revenue	4.12	9.36	12.02	175.87	242.97
Other Current Liabilities	78.21	86.71	100.41	639.43	718.5
Total Current Liabilities	428.55	358.93	380.87	1,657	1,881
Long-Term Debt	-	155.95	276.2	1,032	1,041
Long-Term Leases	16.96	39.73	50.85	65.61	72.17
Long-Term Deferred Tax Liabilities	0.3	0.32	1.36	569.38	642.3
Other Long-Term Liabilities	0.2	0.75	0.37	0.8	0.42
Total Liabilities	446.01	555.68	709.65	3,325	3,637

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	11.25	11.25	11.71	12.05	12.32
Additional Paid-In Capital	1,279	1,279	1,489	2,373	2,382
Retained Earnings	-69.38	-73.37	-82.9	-108.78	-82.55
Treasury Stock	-3.87	-	-	-	-
Comprehensive Income & Other	-34.87	-35.45	-30.99	73.12	203.54
Total Common Equity	1,182	1,181	1,387	2,349	2,516
Minority Interest	-1.23	-1.5	-1.49	1,339	1,445
Shareholders' Equity	1,181	1,180	1,385	3,688	3,961
Total Liabilities & Equity	1,627	1,735	2,095	7,014	7,598

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	337.95	435.41	560.07	1,765	1,804
Net Cash (Debt)	-194.46	-292.71	-368.22	-1,196	-1,174
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.17	-0.26	-0.31	-0.98	-0.95
Filing Date Shares Outstanding	1,114	1,125	1,125	1,205	1,232
Total Common Shares Outstanding	1,125	1,125	1,171	1,205	1,232
Working Capital	170.12	262.09	449.36	1,045	1,007
Book Value Per Share	1.05	1.05	1.18	1.95	2.04
Tangible Book Value	1,182	1,181	1,387	2,349	2,516
Tangible Book Value Per Share	1.05	1.05	1.18	1.95	2.04
Buildings	497.55	494.72	497.06	696.12	703.29
Machinery	167.11	160.96	155.26	216	211.59
Construction In Progress	26.4	20.64	-	-	-
Leasehold Improvements	88.93	83.56	83.18	89.17	94.39

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error